Zoono Group Limited (AU:ZNO)
ASX:ZNO
Want to see AU:ZNO full AI Analyst Report?
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)153.26K
Market Cap
AU$26.81M
Enterprise ValueAU$25.74M
Total Cash (Recent Filing)AU$475.33K
Total Debt (Recent Filing)AU$625.70K
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Structural Market DemandZoono’s core products sit in long‑duration hygiene and infection‑prevention markets where recurring replacement and institutional procurement create steady baseline demand. Presence across consumer, commercial and institutional channels diversifies revenue sources and supports durable addressable markets.
Low LeverageThe company’s low debt load materially reduces near‑term solvency risk and interest burden, giving management flexibility to pursue operational improvements or raise capital if needed. Low leverage is a structural buffer while profitability and cash generation recover.
Top-line ImprovementA positive revenue inflection after declines indicates improving demand or distribution traction. If sustained, continued top‑line growth can leverage fixed costs and is a prerequisite for restoring gross margins and converting to positive operating cash flow over the medium term.
Bears Say
Deep UnprofitabilityExtremely negative margins show the business is not currently generating value from sales; negative gross profit suggests product economics or pricing/cost structure issues. Persistent unprofitability erodes capital and makes funding and long‑term scalability dependent on structural fixes or external support.
Weak Cash GenerationConsistent negative operating cash flow forces the company to rely on external financing, increasing dilution and refinancing risk. Continued cash burn constrains reinvestment in sales, manufacturing, or R&D, making it difficult to convert top‑line gains into sustainable profitability.
Eroded Equity BaseMaterial erosion of shareholder equity over several years leaves a thin capital buffer to absorb further losses. Even with low debt, a depleted equity base weakens financial flexibility, reduces lender/partner confidence, and raises the probability of dilutive capital raises if losses persist.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$26.81M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Aug 20, 2026 which is in 111 days.
How were Zoono Group Limited’s earnings last quarter?
Zoono Group Limited released its earnings results on Feb 19, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Zoono Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.18%
12-Months-Change
Fundamentals
Return on Equity
-108.90%
Trailing 12-Months
Asset Growth
-23.69%
Trailing 12-Months
Company Description
Zoono Group Limited
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.
Technical Analysis
Skin Elements Limited
―
Food Revolution Group Ltd.
―
Fiji Kava Limited
―
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---